OncoImmune competitorsClear all
Spectrum Pharmaceuticals's top competitors include Halozyme Therapeutics.
 Spectrum Pharmaceuticals Spectrum Pharmaceuticals is a biotechnology company developing drugs to treat oncology and hematology. |  Halozyme Therapeutics Halozyme Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment. | |
Founding Date | Founding Date 2002 | Founding Date 1998 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Henderson, US HQ Irvine, US | Locations San Diego, US HQ |
Employees | Employees 14638% decrease | Employees 1363% increase |
Valuation ($) | Valuation ($) 121.8 m | Valuation ($) 6.2 b |
Employee Rating | Employee Rating 2.9 | Employee Rating 3.4 |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $267.6m (FY, 2020) |
Net income | Net income ($160.9m) (FY, 2020) | Net income $129.1m (FY, 2020) |
Operating ⚠ | ||
Phase I Trials Products | Phase I Trials Products 3 (FY, 2016) | Phase I Trials Products 10 (FY, 2020) |
Phase II Trials Products | Phase II Trials Products 1 (FY, 2016) | Phase II Trials Products 1 (FY, 2020) |
Phase III Trials Products | Phase III Trials Products 3 (FY, 2016) | Phase III Trials Products 8 (FY, 2020) |
Funding | ||
Total funding raised | Total funding raised $ 3m | Total funding raised $ 45m |
For sources of this data, please see the company profile
View company profiles
Halozyme Therapeutics
HQ
San Diego, US
Employees
136↑ 3% increase
Halozyme Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
View company